MYCN and acute lymphoblastic leukemia: We show here that MYCN oncogene is overexpressed in a relevant proportion of pediatric T-ALL, in particular in the TAL1+ subgroup, and its selective inhibition by using PNA targeted against MYCN results in the arrest of cell growth and induction of apoptosis both in vitro and in human blast cells from pediatric T-ALL patients.